Dopamine-2 Receptor Antagonist [EPC]

Dopamine-2 Receptor Antagonist [EPC] was reported 7798 times

Drugs of the Dopamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CSF MEASLES ANTIBODY POSITIVE 11 0.8462
1 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 190 0.2750
2 SEXUAL LIFE IMPAIRMENT 13 0.2653
3 RUBELLA ANTIBODY POSITIVE 11 0.1930
4 REFUSAL OF EXAMINATION 25 0.1908
5 EXCESSIVE SEXUAL FANTASIES 11 0.1833
6 ASTEATOSIS 15 0.1271
7 HUMAN BITE 10 0.1205
8 TOBACCO INTERACTION 12 0.1081
9 DISINHIBITION 172 0.1068
10 ENDOCARDITIS ENTEROCOCCAL 15 0.1056
11 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 7 0.1045
12 ANTIPSYCHOTIC DRUG LEVEL DECREASED 55 0.1036
13 ANTICHOLINERGIC EFFECT 7 0.0933
14 NAIL BED INFLAMMATION 28 0.0878
15 BLADDER TRABECULATION 6 0.0741
16 BLOOD BRAIN BARRIER DEFECT 11 0.0724
17 DELUSION OF REFERENCE 10 0.0719
18 REBOUND PSYCHOSIS 15 0.0704
19 WAXY FLEXIBILITY 12 0.0682
20 NEGLECT OF PERSONAL APPEARANCE 16 0.0658
21 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 57 0.0640
22 SPASMODIC DYSPHONIA 19 0.0627
23 ORGANIC BRAIN SYNDROME 11 0.0585
24 SUBACUTE ENDOCARDITIS 6 0.0583
25 SARCOMA METASTATIC 7 0.0504
26 MONOCYTOSIS 31 0.0499
27 PANCREAS INFECTION 20 0.0498
28 ANTIPSYCHOTIC DRUG LEVEL INCREASED 139 0.0493
29 POSTMORTEM BLOOD DRUG LEVEL INCREASED 18 0.0483
30 NASAL MUCOSAL DISORDER 27 0.0463
31 SENSORY OVERLOAD 9 0.0457
32 DRUG-GENETIC INTERACTION 15 0.0420
33 THUNDERCLAP HEADACHE 11 0.0420
34 SCHIZOAFFECTIVE DISORDER 73 0.0409
35 MITRAL VALVE REPLACEMENT 16 0.0404
36 ELECTROCARDIOGRAM QT SHORTENED 12 0.0396
37 POLYDIPSIA PSYCHOGENIC 8 0.0390
38 ALLERGY TEST NEGATIVE 6 0.0385
39 RED BLOOD CELL SEDIMENTATION RATE DECREASED 10 0.0383
40 THERAPEUTIC PRODUCT EFFECT VARIABLE 148 0.0381
41 ONYCHOPHAGIA 10 0.0362
42 EOSINOPHIL COUNT DECREASED 85 0.0357
43 STREPTOCOCCAL SEPSIS 42 0.0354
44 PANCREATIC INJURY 10 0.0328
45 PATIENT ISOLATION 7 0.0326
46 BLADDER INJURY 10 0.0313
47 PLEUROTHOTONUS 27 0.0299
48 PSYCHOTIC SYMPTOM 61 0.0295
49 LEFT VENTRICULAR DILATATION 15 0.0294
50 TRANSFERRIN SATURATION DECREASED 12 0.0281
51 PORTAL FIBROSIS 6 0.0280
52 SCHIZOPHRENIA 339 0.0279
53 OROMANDIBULAR DYSTONIA 20 0.0274
54 SOCIAL ANXIETY DISORDER 18 0.0274
55 NEUROMUSCULAR BLOCKADE 6 0.0268
56 PSEUDOMONAL SEPSIS 46 0.0262
57 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 44 0.0260
58 SEXUALLY INAPPROPRIATE BEHAVIOUR 12 0.0258
59 RENAL CORTICAL NECROSIS 6 0.0258
60 HYPERPROLACTINAEMIA 167 0.0257
61 HEPATOBILIARY DISEASE 16 0.0256
62 SCHIZOPHRENIA, PARANOID TYPE 9 0.0250
63 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 8 0.0249
64 GRANDIOSITY 9 0.0246
65 DELUSION OF GRANDEUR 11 0.0245
66 AKATHISIA 334 0.0245
67 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 17 0.0242
68 THYROXINE FREE DECREASED 13 0.0230
69 BLOOD BILIRUBIN DECREASED 14 0.0227
70 ASPARTATE AMINOTRANSFERASE DECREASED 12 0.0226
71 CEREBRAL ARTERY STENOSIS 11 0.0225
72 OBSESSIVE-COMPULSIVE DISORDER 180 0.0224
73 BLOOD FOLATE DECREASED 16 0.0220
74 BLOOD PROLACTIN INCREASED 103 0.0218
75 TESTICULAR ATROPHY 19 0.0218
76 PROCEDURAL VOMITING 14 0.0215
77 HALLUCINATION, TACTILE 14 0.0210
78 NEUROLEPTIC MALIGNANT SYNDROME 247 0.0208
79 DECREASED EYE CONTACT 6 0.0197
80 METABOLIC SYNDROME 32 0.0195
81 LABELLED DRUG-DRUG INTERACTION ISSUE 28 0.0193
82 DELUSIONAL PERCEPTION 8 0.0193
83 PERSECUTORY DELUSION 48 0.0192
84 MYOCARDITIS 218 0.0190
85 NEUROMUSCULAR BLOCK PROLONGED 7 0.0190
86 PLEOCYTOSIS 11 0.0189
87 MEAN CELL VOLUME DECREASED 29 0.0188
88 DYSLIPIDAEMIA 94 0.0185
89 EUPHORIC MOOD 188 0.0183
90 TROPONIN T INCREASED 23 0.0181
91 MEAN CELL HAEMOGLOBIN DECREASED 33 0.0180
92 CONVULSIVE THRESHOLD LOWERED 7 0.0178
93 RETROGRADE EJACULATION 14 0.0177
94 COGWHEEL RIGIDITY 18 0.0171
95 OBSESSIVE-COMPULSIVE SYMPTOM 6 0.0163
96 HALLUCINATION, OLFACTORY 7 0.0161
97 ACCIDENTAL POISONING 22 0.0160
98 NEUTROPHIL COUNT INCREASED 164 0.0160
99 STENOSIS 30 0.0160
100 SALIVARY HYPERSECRETION 156 0.0156
101 POOR PERSONAL HYGIENE 8 0.0155
102 PROCEDURAL NAUSEA 12 0.0149
103 KETOSIS 16 0.0147
104 CSF PROTEIN INCREASED 12 0.0145
105 HYPERLACTACIDAEMIA 37 0.0138
106 POSTURING 7 0.0135
107 GALLBLADDER INJURY 26 0.0133
108 STEATOHEPATITIS 7 0.0131
109 EXTRAPYRAMIDAL DISORDER 323 0.0130
110 MACROCYTOSIS 15 0.0129
111 SEDATION COMPLICATION 33 0.0129
112 CATATONIA 67 0.0127
113 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 13 0.0122
114 AORTIC VALVE REPLACEMENT 15 0.0120
115 HYPOCHROMIC ANAEMIA 12 0.0118
116 HEPATITIS A 10 0.0118
117 MUTISM 17 0.0117
118 WRONG PATIENT RECEIVED PRODUCT 34 0.0116
119 HALLUCINATION, AUDITORY 183 0.0115
120 FOOD REFUSAL 10 0.0114
121 SUSPICIOUSNESS 8 0.0114
122 SITTING DISABILITY 7 0.0114
123 HYPERLEUKOCYTOSIS 10 0.0113
124 BORDERLINE PERSONALITY DISORDER 8 0.0113
125 BLOOD UREA DECREASED 14 0.0113
126 OCULOGYRIC CRISIS 24 0.0112
127 HEMIANOPIA 11 0.0111
128 DELUSION 172 0.0111
129 SEMEN VOLUME DECREASED 11 0.0110
130 SLEEP DEFICIT 23 0.0109
131 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 18 0.0108
132 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 6 0.0108
133 PSYCHOMOTOR RETARDATION 30 0.0107
134 ANOSOGNOSIA 8 0.0104
135 ACUTE LEFT VENTRICULAR FAILURE 7 0.0104
136 TROPONIN INCREASED 79 0.0104
137 RETROPERITONEAL FIBROSIS 6 0.0103
138 BINGE EATING 11 0.0102
139 LEFT ATRIAL DILATATION 13 0.0102
140 DIARRHOEA INFECTIOUS 8 0.0102
141 MICROCYTIC ANAEMIA 21 0.0101
142 COMPULSIVE SEXUAL BEHAVIOUR 8 0.0099
143 AUTONOMIC NEUROPATHY 10 0.0099
144 PARKINSONISM 96 0.0098
145 UTERINE PAIN 10 0.0097
146 FOCAL DYSCOGNITIVE SEIZURES 11 0.0097
147 ELECTROCARDIOGRAM T WAVE ABNORMAL 15 0.0096
148 INCREASED APPETITE 179 0.0094
149 VASCULAR DEVICE INFECTION 42 0.0092
150 LEUKAEMIA 87 0.0092
151 EJACULATION FAILURE 18 0.0090
152 ELECTROCARDIOGRAM QT PROLONGED 322 0.0089
153 PULMONARY VALVE INCOMPETENCE 13 0.0089
154 ANTICHOLINERGIC SYNDROME 14 0.0088
155 STUPOR 28 0.0087
156 IMPAIRED SELF-CARE 18 0.0087
157 SERUM FERRITIN DECREASED 15 0.0087
158 KIDNEY FIBROSIS 15 0.0086
159 SYSTOLIC DYSFUNCTION 9 0.0085
160 DELAYED RECOVERY FROM ANAESTHESIA 8 0.0084
161 PENILE SIZE REDUCED 8 0.0084
162 ALCOHOL ABUSE 22 0.0082
163 PSYCHOTIC DISORDER 242 0.0082
164 HYPERTENSIVE HEART DISEASE 15 0.0080
165 INTESTINAL PSEUDO-OBSTRUCTION 7 0.0080
166 NEGATIVISM 6 0.0079
167 UPPER AIRWAY OBSTRUCTION 7 0.0079
168 REDUCED FACIAL EXPRESSION 8 0.0079
169 INTESTINAL INFARCTION 7 0.0077
170 GRIMACING 6 0.0077
171 MENTAL IMPAIRMENT 184 0.0076
172 DRUG SCREEN FALSE POSITIVE 21 0.0076
173 ABULIA 7 0.0076
174 OBESITY 120 0.0075
175 DYSTONIA 146 0.0075
176 NEGATIVE THOUGHTS 22 0.0075
177 HYPERAMMONAEMIC ENCEPHALOPATHY 13 0.0075
178 OVERWEIGHT 40 0.0074
179 SEDATION 195 0.0074
180 RESPIRATORY DEPRESSION 91 0.0074
181 TONGUE BITING 15 0.0073
182 ACUTE PULMONARY OEDEMA 40 0.0071
183 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 14 0.0071
184 LONG QT SYNDROME 17 0.0071
185 AUDITORY DISORDER 10 0.0070
186 ARTERIOSCLEROSIS CORONARY ARTERY 46 0.0069
187 ACUTE PSYCHOSIS 17 0.0069
188 BREAST ABSCESS 7 0.0069
189 CHOLECYSTITIS INFECTIVE 19 0.0068
190 POSTICTAL STATE 7 0.0067
191 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
192 HYPERTHERMIA MALIGNANT 10 0.0067
193 GALACTORRHOEA 42 0.0065
194 LEUKOPENIA 324 0.0065
195 VICTIM OF CRIME 8 0.0065
196 POSTURE ABNORMAL 21 0.0064
197 WHITE BLOOD CELL COUNT INCREASED 247 0.0064
198 VARICOSE VEIN 33 0.0064
199 DYSPHEMIA 28 0.0064
200 HEPATITIS E 10 0.0063
201 LEFT VENTRICULAR DYSFUNCTION 42 0.0063
202 HYPOVENTILATION 20 0.0061
203 PSYCHOMOTOR SKILLS IMPAIRED 16 0.0061
204 VASOPLEGIA SYNDROME 10 0.0061
205 PRIAPISM 21 0.0061
206 ANTISOCIAL BEHAVIOUR 6 0.0060
207 ATRIOVENTRICULAR BLOCK FIRST DEGREE 26 0.0060
208 TESTICULAR PAIN 19 0.0060
209 CORONARY ARTERY STENOSIS 30 0.0060
210 HEPATIC CYTOLYSIS 76 0.0060
211 FOAMING AT MOUTH 12 0.0059
212 DROWNING 6 0.0059
213 METASTASES TO LYMPH NODES 40 0.0059
214 PARONYCHIA 26 0.0059
215 MYOGLOBIN BLOOD INCREASED 9 0.0059
216 SKIN DEPIGMENTATION 8 0.0059
217 AKINESIA 12 0.0058
218 MONOCYTE COUNT INCREASED 21 0.0058
219 HYPOMANIA 21 0.0057
220 PRESCRIBED OVERDOSE 110 0.0057
221 SOPOR 75 0.0057
222 PSYCHIATRIC DECOMPENSATION 11 0.0056
223 VENTRICULAR HYPOKINESIA 18 0.0056
224 MUSCLE RIGIDITY 67 0.0056
225 ORCHITIS 6 0.0056
226 SINUS TACHYCARDIA 79 0.0056
227 VITAMIN B12 DECREASED 16 0.0055
228 BLOOD PHOSPHORUS INCREASED 15 0.0055
229 FAECALOMA 30 0.0055
230 LOGORRHOEA 19 0.0054
231 CRYPTORCHISM 6 0.0053
232 DISTRIBUTIVE SHOCK 12 0.0053
233 PULMONARY GRANULOMA 6 0.0053
234 HALLUCINATION, VISUAL 111 0.0053
235 DRUG LEVEL INCREASED 87 0.0053
236 ANION GAP INCREASED 7 0.0052
237 CARDIOMYOPATHY 76 0.0051
238 EXOPHTHALMOS 11 0.0051
239 VOLVULUS 12 0.0051
240 HALLUCINATIONS, MIXED 21 0.0050
241 NEUTROPHIL COUNT ABNORMAL 14 0.0049
242 SLOW SPEECH 12 0.0049
243 PITUITARY TUMOUR BENIGN 8 0.0049
244 LEFT VENTRICULAR HYPERTROPHY 21 0.0049
245 DISORGANISED SPEECH 9 0.0049
246 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
247 DEPRESSIVE SYMPTOM 17 0.0048
248 PARANOIA 83 0.0048
249 SUICIDE ATTEMPT 291 0.0048
250 FLAT AFFECT 11 0.0047
251 RESTLESSNESS 173 0.0047
252 TORSADE DE POINTES 37 0.0047
253 ILEUS PARALYTIC 21 0.0047
254 INTENTIONAL SELF-INJURY 95 0.0047
255 HYPOREFLEXIA 9 0.0047
256 IRON DEFICIENCY 21 0.0047
257 LEUKOCYTOSIS 84 0.0046
258 BEHAVIOUR DISORDER 25 0.0046
259 SELF INJURIOUS BEHAVIOUR 14 0.0046
260 BLOOD CREATINE PHOSPHOKINASE INCREASED 131 0.0045
261 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
262 HEPATITIS ACUTE 29 0.0045
263 FEAR OF DEATH 10 0.0044
264 IDIOPATHIC THROMBOCYTOPENIC PURPURA 7 0.0044
265 STRABISMUS 13 0.0044
266 NEUTROPHILIA 25 0.0044
267 RED BLOOD CELL COUNT INCREASED 12 0.0043
268 OLIGURIA 27 0.0043
269 NEUTROPHIL COUNT DECREASED 175 0.0043
270 LYMPHOCYTE COUNT INCREASED 14 0.0043
271 LINEAR IGA DISEASE 7 0.0042
272 HIGH DENSITY LIPOPROTEIN DECREASED 14 0.0042
273 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 11 0.0042
274 DROOLING 29 0.0042
275 TONGUE OEDEMA 16 0.0042
276 MENINGITIS BACTERIAL 6 0.0042
277 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
278 AUTONOMIC NERVOUS SYSTEM IMBALANCE 12 0.0041
279 GAMBLING DISORDER 11 0.0041
280 FIXED ERUPTION 7 0.0041
281 APRAXIA 6 0.0040
282 CLUMSINESS 11 0.0040
283 ASPIRATION 44 0.0040
284 C-REACTIVE PROTEIN INCREASED 145 0.0040
285 KOUNIS SYNDROME 9 0.0040
286 INTRACRANIAL PRESSURE INCREASED 22 0.0039
287 ANAPHYLACTIC SHOCK 101 0.0039
288 MYDRIASIS 50 0.0039
289 DRUG MONITORING PROCEDURE NOT PERFORMED 7 0.0039
290 DIASTOLIC DYSFUNCTION 12 0.0039
291 POTENTIATING DRUG INTERACTION 13 0.0039
292 SUBILEUS 8 0.0038
293 ELECTROCARDIOGRAM ABNORMAL 30 0.0038
294 TORTICOLLIS 8 0.0038
295 NECROSIS 21 0.0038
296 SUBSTANCE USE DISORDER 12 0.0038
297 HYPERACUSIS 14 0.0038
298 THINKING ABNORMAL 70 0.0038
299 BRAIN OEDEMA 47 0.0037
300 BLOOD BICARBONATE DECREASED 7 0.0037
301 DRUG INTERACTION 579 0.0036
302 ILLUSION 6 0.0036
303 PLATELET COUNT INCREASED 47 0.0036
304 AGGRESSION 180 0.0036
305 ELECTRIC SHOCK SENSATION 10 0.0036
306 BRAIN DEATH 11 0.0036
307 IMMUNE THROMBOCYTOPENIC PURPURA 10 0.0035
308 VENTRICULAR FIBRILLATION 39 0.0035
309 SEXUAL DYSFUNCTION 41 0.0035
310 BUNDLE BRANCH BLOCK RIGHT 16 0.0035
311 TREATMENT NONCOMPLIANCE 190 0.0035
312 REACTION TO EXCIPIENT 8 0.0035
313 MICTURITION DISORDER 12 0.0035
314 HYPERTHYROIDISM 50 0.0035
315 COMA SCALE ABNORMAL 10 0.0034
316 HANGOVER 12 0.0034
317 KYPHOSIS 6 0.0034
318 SEROTONIN SYNDROME 65 0.0034
319 SOCIAL PROBLEM 14 0.0034
320 APATHY 49 0.0034
321 CONGESTIVE CARDIOMYOPATHY 14 0.0034
322 ANAESTHETIC COMPLICATION 9 0.0033
323 PHYSICAL ASSAULT 7 0.0033
324 BRUXISM 18 0.0033
325 OBSESSIVE THOUGHTS 6 0.0033
326 CIRCULATORY COLLAPSE 56 0.0033
327 VENTRICULAR ARRHYTHMIA 12 0.0033
328 THROMBOCYTOSIS 12 0.0033
329 DRUG ABUSE 272 0.0033
330 TYPE 2 DIABETES MELLITUS 109 0.0032
331 MANIA 53 0.0032
332 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 229 0.0032
333 VENTRICULAR HYPERTROPHY 8 0.0032
334 MYOCLONUS 38 0.0032
335 TACHYCARDIA 283 0.0032
336 ASPHYXIA 26 0.0032
337 ELECTROENCEPHALOGRAM ABNORMAL 10 0.0032
338 HOSTILITY 8 0.0031
339 SUDDEN DEATH 33 0.0031
340 AGITATION 229 0.0031
341 SOCIAL AVOIDANT BEHAVIOUR 18 0.0031
342 NEUTROPENIA 418 0.0031
343 POISONING DELIBERATE 29 0.0031
344 DRUG LEVEL ABOVE THERAPEUTIC 14 0.0031
345 LYMPHOCYTE COUNT DECREASED 54 0.0031
346 PANCREATITIS NECROTISING 7 0.0030
347 AGRANULOCYTOSIS 56 0.0030
348 ALTERED STATE OF CONSCIOUSNESS 65 0.0030
349 FOOD POISONING 16 0.0030
350 HOMICIDAL IDEATION 12 0.0030
351 B-CELL LYMPHOMA 10 0.0029
352 PETIT MAL EPILEPSY 15 0.0029
353 STRESS CARDIOMYOPATHY 17 0.0029
354 BRADYPHRENIA 19 0.0029
355 DIABETES INSIPIDUS 7 0.0029
356 RHABDOMYOLYSIS 121 0.0029
357 STARING 7 0.0029
358 BLOOD CREATININE DECREASED 9 0.0029
359 ORTHOSTATIC HYPOTENSION 50 0.0029
360 METASTASES TO CENTRAL NERVOUS SYSTEM 37 0.0029
361 POISONING 36 0.0029
362 HEART VALVE INCOMPETENCE 8 0.0028
363 HYPERTHERMIA 21 0.0027
364 BREAST ENLARGEMENT 9 0.0027
365 MITRAL VALVE INCOMPETENCE 31 0.0027
366 CANCER PAIN 7 0.0027
367 SENSORY LOSS 22 0.0027
368 ENURESIS 11 0.0027
369 BLEPHAROSPASM 17 0.0027
370 POLYURIA 22 0.0027
371 DEMYELINATION 11 0.0027
372 METASTASES TO SPINE 9 0.0027
373 TARDIVE DYSKINESIA 75 0.0027
374 TOXICITY TO VARIOUS AGENTS 443 0.0026
375 NEUROLOGICAL DECOMPENSATION 6 0.0026
376 TONGUE DISCOMFORT 11 0.0026
377 ANORGASMIA 7 0.0026
378 DYSPHORIA 13 0.0026
379 HYPERTRIGLYCERIDAEMIA 15 0.0026
380 TYPE I HYPERSENSITIVITY 9 0.0026
381 CANDIDA INFECTION 43 0.0025
382 SUSPECTED COUNTERFEIT PRODUCT 10 0.0025
383 PULSE ABSENT 12 0.0025
384 TRICUSPID VALVE INCOMPETENCE 20 0.0025
385 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
386 HAEMODYNAMIC INSTABILITY 19 0.0025
387 EPILEPSY 76 0.0025
388 EMPHYSEMA 25 0.0025
389 PARADOXICAL DRUG REACTION 9 0.0024
390 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
391 HYPERNATRAEMIA 12 0.0024
392 HYPOTONIA 24 0.0024
393 OLIGOHYDRAMNIOS 8 0.0024
394 CARDIO-RESPIRATORY ARREST 100 0.0024
395 SINUS BRADYCARDIA 23 0.0024
396 ERECTILE DYSFUNCTION 61 0.0024
397 HYPOTHERMIA 24 0.0024
398 EXCORIATION 6 0.0024
399 LIP OEDEMA 10 0.0024
400 SUICIDAL IDEATION 216 0.0024
401 HEPATITIS FULMINANT 7 0.0024
402 BRONCHOPNEUMONIA 8 0.0023
403 LOSS OF LIBIDO 21 0.0023
404 COMA 111 0.0023
405 MENTAL DISORDER 101 0.0023
406 APNOEA 18 0.0023
407 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
408 BEDRIDDEN 30 0.0023
409 MUSCLE CONTRACTIONS INVOLUNTARY 8 0.0023
410 FIBROSIS 7 0.0023
411 ATAXIA 27 0.0023
412 HAEMATOCRIT DECREASED 45 0.0023
413 DELIRIUM 78 0.0022
414 MIOSIS 18 0.0022
415 WHITE BLOOD CELL COUNT DECREASED 242 0.0022
416 LARYNGOSPASM 6 0.0022
417 AMENORRHOEA 39 0.0022
418 DRUG RESISTANCE 57 0.0022
419 ANURIA 19 0.0022
420 ENCEPHALOPATHY 53 0.0022
421 ABNORMAL BEHAVIOUR 85 0.0021
422 SELF-INJURIOUS IDEATION 9 0.0021
423 UMBILICAL HERNIA 10 0.0021
424 IMPULSIVE BEHAVIOUR 8 0.0021
425 METABOLIC ACIDOSIS 68 0.0021
426 BUNDLE BRANCH BLOCK LEFT 9 0.0021
427 PARTIAL SEIZURES 11 0.0021
428 FAECAL INCONTINENCE 10 0.0021
429 PNEUMONIA ASPIRATION 52 0.0021
430 HYPERCHOLESTEROLAEMIA 20 0.0021
431 EATING DISORDER 44 0.0021
432 DIABETIC RETINOPATHY 7 0.0021
433 VENTRICULAR TACHYCARDIA 34 0.0021
434 GASTROINTESTINAL NECROSIS 6 0.0021
435 GAMMA-GLUTAMYLTRANSFERASE INCREASED 45 0.0020
436 WEIGHT INCREASED 448 0.0020
437 SYNOVITIS 36 0.0020
438 FIBRIN D DIMER INCREASED 7 0.0020
439 COGNITIVE DISORDER 90 0.0019
440 THERAPY PARTIAL RESPONDER 30 0.0019
441 AFFECTIVE DISORDER 15 0.0019
442 ABNORMAL LOSS OF WEIGHT 13 0.0019
443 DISORIENTATION 75 0.0019
444 SCREAMING 12 0.0019
445 MOTOR DYSFUNCTION 19 0.0019
446 ENERGY INCREASED 11 0.0019
447 TENSION HEADACHE 8 0.0019
448 URINARY INCONTINENCE 55 0.0019
449 DYSKINESIA 75 0.0018
450 DEPRESSED LEVEL OF CONSCIOUSNESS 73 0.0018
451 SUBSTANCE ABUSE 15 0.0018
452 MULTIPLE DRUG OVERDOSE 9 0.0018
453 CARDIOTOXICITY 16 0.0018
454 CHOLECYSTITIS CHRONIC 12 0.0018
455 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46 0.0018
456 BLOOD ALKALINE PHOSPHATASE INCREASED 44 0.0018
457 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 12 0.0018
458 SUDDEN CARDIAC DEATH 6 0.0018
459 CEREBRAL ATROPHY 7 0.0018
460 HYPERPHAGIA 7 0.0018
461 BIPOLAR DISORDER 19 0.0017
462 HYPERTONIA 10 0.0017
463 DEPRESSION SUICIDAL 6 0.0017
464 GRAND MAL CONVULSION 16 0.0017
465 ENTEROCOLITIS 10 0.0017
466 LOWER RESPIRATORY TRACT INFECTION 78 0.0017
467 EOSINOPHILIA 30 0.0017
468 BLOOD LACTIC ACID INCREASED 9 0.0017
469 INCONTINENCE 18 0.0017
470 DEPRESSED MOOD 90 0.0017
471 ACIDOSIS 13 0.0017
472 CARDIAC ARREST 140 0.0017
473 GENERALISED TONIC-CLONIC SEIZURE 28 0.0017
474 PANCREATITIS ACUTE 38 0.0017
475 SUICIDAL BEHAVIOUR 7 0.0017
476 EOSINOPHIL COUNT INCREASED 14 0.0017
477 CONFUSIONAL STATE 271 0.0017
478 HYPOGAMMAGLOBULINAEMIA 11 0.0017
479 BONE LESION 6 0.0017
480 LIVER FUNCTION TEST ABNORMAL 48 0.0016
481 HYPERGLYCAEMIA 60 0.0016
482 BLOOD PHOSPHORUS DECREASED 6 0.0016
483 BLOOD ALBUMIN DECREASED 13 0.0016
484 UNRESPONSIVE TO STIMULI 42 0.0016
485 SPEECH DISORDER 85 0.0016
486 DRUG TOXICITY 22 0.0016
487 EYE MOVEMENT DISORDER 11 0.0016
488 INTENTIONAL OVERDOSE 103 0.0016
489 HALLUCINATION 121 0.0016
490 PROTEIN TOTAL DECREASED 6 0.0016
491 REBOUND EFFECT 18 0.0016
492 LACTIC ACIDOSIS 51 0.0016
493 SLEEP APNOEA SYNDROME 30 0.0016
494 ENDOCARDITIS 8 0.0016
495 AFFECT LABILITY 15 0.0016
496 HEPATIC STEATOSIS 29 0.0016
497 LYMPHOMA 24 0.0016
498 TRISMUS 8 0.0015
499 DRUG USE DISORDER 13 0.0015
500 RESTLESS LEGS SYNDROME 28 0.0015
501 HAEMOGLOBIN INCREASED 7 0.0015
502 IRRITABILITY 92 0.0015
503 BRADYKINESIA 9 0.0015
504 RENAL FAILURE ACUTE 64 0.0015
505 NYSTAGMUS 8 0.0015
506 STATUS EPILEPTICUS 17 0.0015
507 SOMNOLENCE 303 0.0015
508 HYPERSOMNIA 43 0.0015
509 CONTRAINDICATED PRODUCT ADMINISTERED 45 0.0015
510 LYMPHOPENIA 21 0.0015
511 EJECTION FRACTION DECREASED 23 0.0015
512 DRUG LEVEL DECREASED 15 0.0015
513 INTESTINAL ISCHAEMIA 8 0.0015
514 HYPONATRAEMIA 81 0.0014
515 WITHDRAWAL SYNDROME 60 0.0014
516 HYPERLIPIDAEMIA 17 0.0014
517 LOSS OF CONSCIOUSNESS 182 0.0014
518 ARRHYTHMIA 67 0.0014
519 INFLAMMATORY MARKER INCREASED 7 0.0014
520 VITAMIN D DECREASED 12 0.0014
521 HYPERAMMONAEMIA 7 0.0014
522 CHOKING 27 0.0014
523 HYPOKINESIA 20 0.0014
524 FEAR 37 0.0014
525 IMMOBILE 6 0.0014
526 BODY TEMPERATURE INCREASED 28 0.0014
527 PANIC ATTACK 50 0.0014
528 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
529 PERIPHERAL VASCULAR DISORDER 7 0.0014
530 BLOOD TRIGLYCERIDES INCREASED 24 0.0014
531 HYPOTENSION 272 0.0014
532 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
533 VENTRICULAR EXTRASYSTOLES 14 0.0013
534 FEELING DRUNK 10 0.0013
535 IMPLANT SITE PAIN 6 0.0013
536 HYDRONEPHROSIS 10 0.0013
537 ALANINE AMINOTRANSFERASE INCREASED 82 0.0013
538 SKIN FISSURES 26 0.0013
539 PAROSMIA 10 0.0013
540 MYOCARDIAL ISCHAEMIA 15 0.0013
541 HAEMOGLOBIN DECREASED 135 0.0013
542 TENSION 8 0.0013
543 DISSOCIATION 10 0.0013
544 DYSARTHRIA 49 0.0013
545 CARDIOMEGALY 16 0.0013
546 IRON DEFICIENCY ANAEMIA 12 0.0013
547 TOXIC SKIN ERUPTION 13 0.0013
548 PULMONARY CONGESTION 17 0.0013
549 ILEUS 16 0.0013
550 SPLENOMEGALY 15 0.0013
551 SUSPECTED SUICIDE 6 0.0013
552 MYOPATHY 11 0.0013
553 TRANSAMINASES INCREASED 28 0.0013
554 BLOOD DISORDER 10 0.0012
555 THERAPY NON-RESPONDER 56 0.0012
556 DISTURBANCE IN ATTENTION 67 0.0012
557 VITAMIN D DEFICIENCY 12 0.0012
558 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
559 PSYCHIATRIC SYMPTOM 9 0.0012
560 OVERDOSE 261 0.0012
561 HEPATOCELLULAR INJURY 17 0.0012
562 CHOLESTASIS 23 0.0012
563 BRAIN INJURY 12 0.0012
564 PRODUCT PRESCRIBING ISSUE 26 0.0012
565 BRONCHOSPASM 17 0.0012
566 JAUNDICE 32 0.0012
567 COLITIS ISCHAEMIC 8 0.0012
568 AMNESIA 77 0.0012
569 PLEURISY 7 0.0012
570 SHOCK 27 0.0012
571 INITIAL INSOMNIA 12 0.0012
572 ARTERIOSCLEROSIS 11 0.0012
573 RASH MACULO-PAPULAR 26 0.0012
574 GASTROENTERITIS 17 0.0012
575 GYNAECOMASTIA 36 0.0012
576 RESPIRATORY ARREST 32 0.0012
577 HIATUS HERNIA 15 0.0012
578 ANAPHYLACTIC REACTION 63 0.0011
579 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
580 LOW BIRTH WEIGHT BABY 9 0.0011
581 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 59 0.0011
582 ATRIAL FLUTTER 9 0.0011
583 PERICARDIAL EFFUSION 26 0.0011
584 RED BLOOD CELL COUNT DECREASED 32 0.0011
585 VERTIGO 67 0.0011
586 CHOKING SENSATION 6 0.0011
587 URINARY RETENTION 36 0.0011
588 CONJUNCTIVITIS 20 0.0011
589 HEAD INJURY 34 0.0011
590 NEPHROPATHY TOXIC 12 0.0011
591 CONSTIPATION 232 0.0011
592 RESPIRATORY FAILURE 77 0.0011
593 TREMOR 175 0.0011
594 PLEURAL EFFUSION 64 0.0011
595 CARDIOGENIC SHOCK 15 0.0010
596 WRONG PRODUCT ADMINISTERED 7 0.0010
597 ATELECTASIS 10 0.0010
598 METABOLIC DISORDER 6 0.0010
599 GENERAL PHYSICAL CONDITION ABNORMAL 7 0.0010
600 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8 0.0010
601 HYPERTENSION 216 0.0010
602 THIRST 18 0.0010
603 HEMIPARESIS 17 0.0010
604 BRADYCARDIA 53 0.0010
605 MUSCLE TWITCHING 23 0.0010
606 HEPATITIS C 12 0.0010
607 PULMONARY OEDEMA 44 0.0010
608 POOR QUALITY SLEEP 21 0.0010
609 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
610 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
611 PRODUCT USE IN UNAPPROVED INDICATION 238 0.0010
612 SEPSIS 107 0.0010
613 BLOOD UREA INCREASED 16 0.0010
614 INTENTIONAL PRODUCT MISUSE 83 0.0009
615 HYPERHIDROSIS 121 0.0009
616 LETHARGY 54 0.0009
617 PLATELET COUNT DECREASED 100 0.0009
618 HYPOXIA 33 0.0009
619 BREAST CANCER METASTATIC 10 0.0009
620 RENAL TUBULAR NECROSIS 9 0.0009
621 HYPOKALAEMIA 42 0.0009
622 SLEEP DISORDER 64 0.0009
623 INTESTINAL OBSTRUCTION 34 0.0009
624 SMALL INTESTINAL OBSTRUCTION 11 0.0009
625 TREATMENT FAILURE 74 0.0009
626 ABNORMAL WEIGHT GAIN 11 0.0009
627 SKIN ULCER 23 0.0009
628 RENAL CYST 7 0.0009
629 HEPATIC ENZYME INCREASED 60 0.0009
630 GINGIVAL BLEEDING 12 0.0009
631 INFARCTION 6 0.0009
632 SEIZURE 101 0.0009
633 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
634 THROMBOCYTOPENIA 97 0.0009
635 ENCEPHALITIS 6 0.0009
636 CARDIOVASCULAR DISORDER 22 0.0009
637 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
638 DECUBITUS ULCER 7 0.0009
639 DIARRHOEA HAEMORRHAGIC 8 0.0009
640 LIVER INJURY 21 0.0009
641 CHOLELITHIASIS 28 0.0009
642 JOINT DISLOCATION 9 0.0009
643 BREAST PAIN 9 0.0008
644 BLOOD CHOLESTEROL INCREASED 39 0.0008
645 INFLAMMATION 43 0.0008
646 PANIC REACTION 6 0.0008
647 PELVIC PAIN 15 0.0008
648 CORONARY ARTERY DISEASE 25 0.0008
649 MAJOR DEPRESSION 6 0.0008
650 HEPATITIS 21 0.0008
651 HYPOTHYROIDISM 26 0.0008
652 ACUTE KIDNEY INJURY 124 0.0008
653 MULTI-ORGAN FAILURE 14 0.0008
654 MEDICATION ERROR 45 0.0008
655 DRUG WITHDRAWAL SYNDROME 71 0.0008
656 THERAPEUTIC RESPONSE DECREASED 49 0.0008
657 CYST 10 0.0008
658 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
659 BLOOD CALCIUM DECREASED 9 0.0008
660 DEEP VEIN THROMBOSIS 52 0.0008
661 CONDITION AGGRAVATED 243 0.0008
662 BLOOD PRESSURE DECREASED 53 0.0008
663 HEPATIC FAILURE 24 0.0008
664 HYPOCALCAEMIA 15 0.0008
665 PULMONARY EMBOLISM 75 0.0008
666 HAEMATURIA 27 0.0008
667 ANXIETY 224 0.0008
668 SLUGGISHNESS 8 0.0008
669 RENAL FAILURE CHRONIC 6 0.0008
670 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
671 GASTROINTESTINAL CARCINOMA 7 0.0008
672 CONVULSION 44 0.0008
673 CYANOSIS 12 0.0008
674 GASTRITIS 20 0.0008
675 ECZEMA 39 0.0007
676 HEPATIC CIRRHOSIS 14 0.0007
677 MUSCLE TIGHTNESS 12 0.0007
678 NO THERAPEUTIC RESPONSE 9 0.0007
679 CARDIAC DISORDER 69 0.0007
680 TACHYPNOEA 10 0.0007
681 ANGINA PECTORIS 21 0.0007
682 POST PROCEDURAL COMPLICATION 14 0.0007
683 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
684 HAEMOPTYSIS 20 0.0007
685 PHARYNGEAL SWELLING 7 0.0007
686 SKIN INFECTION 8 0.0007
687 FACE OEDEMA 12 0.0007
688 DRUG INEFFECTIVE 933 0.0007
689 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20 0.0007
690 BLOOD BILIRUBIN INCREASED 19 0.0007
691 INSOMNIA 187 0.0007
692 OVARIAN CYST 7 0.0007
693 SKIN HYPERPIGMENTATION 6 0.0007
694 APHASIA 21 0.0007
695 BLOOD SODIUM DECREASED 13 0.0007
696 HYPOGLYCAEMIA 33 0.0007
697 ACUTE RESPIRATORY FAILURE 13 0.0007
698 METASTASES TO BONE 11 0.0007
699 DRUG-INDUCED LIVER INJURY 21 0.0007
700 DIABETES MELLITUS 51 0.0007
701 ATRIAL FIBRILLATION 65 0.0007
702 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
703 HYPOPHAGIA 17 0.0007
704 PALLOR 18 0.0007
705 ACUTE HEPATIC FAILURE 9 0.0007
706 DISABILITY 13 0.0007
707 HYPOACUSIS 28 0.0006
708 CARDIAC FAILURE 52 0.0006
709 HYPOMAGNESAEMIA 9 0.0006
710 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
711 OESOPHAGITIS 7 0.0006
712 MUSCULOSKELETAL STIFFNESS 56 0.0006
713 LACERATION 6 0.0006
714 CHEST PAIN 117 0.0006
715 PARAESTHESIA ORAL 9 0.0006
716 MOVEMENT DISORDER 20 0.0006
717 ANOSMIA 9 0.0006
718 INFUSION SITE PAIN 8 0.0006
719 DIZZINESS POSTURAL 6 0.0006
720 EAR PAIN 12 0.0006
721 EMOTIONAL DISORDER 19 0.0006
722 MALAISE 268 0.0006
723 LIVER FUNCTION TEST INCREASED 13 0.0006
724 CRYING 22 0.0006
725 VOMITING 284 0.0006
726 EYELID OEDEMA 7 0.0006
727 CAESAREAN SECTION 7 0.0006
728 QUALITY OF LIFE DECREASED 8 0.0006
729 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
730 HAEMATEMESIS 15 0.0006
731 TEMPERATURE INTOLERANCE 6 0.0006
732 TENDONITIS 9 0.0006
733 DEPRESSION 132 0.0006
734 NOCTURIA 7 0.0006
735 PULMONARY HYPERTENSION 12 0.0006
736 RESPIRATORY TRACT INFECTION 15 0.0006
737 HEART RATE INCREASED 57 0.0006
738 CYTOPENIA 7 0.0006
739 NEUROTOXICITY 10 0.0006
740 RESPIRATORY DISORDER 17 0.0006
741 BALANCE DISORDER 49 0.0006
742 FALL 186 0.0006
743 MENSTRUATION DELAYED 6 0.0006
744 PANCREATITIS 29 0.0005
745 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
746 PRODUCT PRESCRIBING ERROR 13 0.0005
747 NERVOUS SYSTEM DISORDER 17 0.0005
748 GENERAL PHYSICAL HEALTH DETERIORATION 63 0.0005
749 DIABETIC KETOACIDOSIS 13 0.0005
750 NERVE INJURY 6 0.0005
751 PANCYTOPENIA 30 0.0005
752 MALNUTRITION 6 0.0005
753 PERICARDITIS 9 0.0005
754 LUNG NEOPLASM MALIGNANT 22 0.0005
755 DRUG INTOLERANCE 51 0.0005
756 DISEASE RECURRENCE 25 0.0005
757 FEELING JITTERY 10 0.0005
758 ADVERSE DRUG REACTION 47 0.0005
759 NIGHTMARE 18 0.0005
760 INFLUENZA 58 0.0005
761 DYSURIA 19 0.0005
762 HOSPITALISATION 79 0.0005
763 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
764 HEAD DISCOMFORT 9 0.0005
765 PNEUMOTHORAX 8 0.0005
766 SCIATICA 8 0.0005
767 BLOOD PRESSURE FLUCTUATION 12 0.0005
768 BLOOD TEST ABNORMAL 7 0.0005
769 ANHEDONIA 13 0.0005
770 BLOOD CREATININE INCREASED 32 0.0005
771 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
772 DRY EYE 24 0.0005
773 VIRAL INFECTION 16 0.0005
774 EMOTIONAL DISTRESS 58 0.0005
775 ACUTE MYOCARDIAL INFARCTION 14 0.0005
776 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
777 PYREXIA 164 0.0005
778 RESPIRATORY DISTRESS 13 0.0005
779 SYNCOPE 47 0.0005
780 PALPITATIONS 55 0.0005
781 MENTAL STATUS CHANGES 13 0.0005
782 DIPLOPIA 12 0.0005
783 OFF LABEL USE 404 0.0005
784 ABDOMINAL PAIN 107 0.0005
785 COMPLETED SUICIDE 38 0.0005
786 PHARYNGEAL OEDEMA 7 0.0005
787 LIMB DISCOMFORT 14 0.0005
788 THERAPY CESSATION 23 0.0004
789 ANAEMIA 85 0.0004
790 VISUAL IMPAIRMENT 55 0.0004
791 OROPHARYNGEAL PAIN 41 0.0004
792 MYOCARDIAL INFARCTION 77 0.0004
793 RESPIRATORY TRACT CONGESTION 7 0.0004
794 SEPTIC SHOCK 19 0.0004
795 ABNORMAL DREAMS 12 0.0004
796 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
797 BLOOD POTASSIUM DECREASED 13 0.0004
798 ORAL DISCOMFORT 6 0.0004
799 BLOOD PRESSURE INCREASED 66 0.0004
800 BLOOD POTASSIUM INCREASED 7 0.0004
801 APHONIA 6 0.0004
802 HEPATIC FUNCTION ABNORMAL 16 0.0004
803 DRUG ADMINISTRATION ERROR 13 0.0004
804 MEMORY IMPAIRMENT 58 0.0004
805 HYPOAESTHESIA 63 0.0004
806 DIZZINESS 207 0.0004
807 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
808 DRUG EFFECT INCOMPLETE 15 0.0004
809 OEDEMA PERIPHERAL 50 0.0004
810 HAEMORRHOIDS 8 0.0004
811 ACCIDENTAL OVERDOSE 15 0.0004
812 MOOD ALTERED 11 0.0004
813 AGEUSIA 10 0.0004
814 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
815 FEEDING DISORDER 8 0.0004
816 DRUG DISPENSING ERROR 6 0.0004
817 FEELING HOT 24 0.0004
818 OXYGEN SATURATION DECREASED 22 0.0004
819 PNEUMONIA 125 0.0004
820 SWOLLEN TONGUE 12 0.0004
821 COVID-19 67 0.0004
822 DYSSTASIA 11 0.0004
823 ABSCESS 6 0.0004
824 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
825 DEHYDRATION 50 0.0004
826 SENSORY DISTURBANCE 6 0.0004
827 ABDOMINAL DISTENSION 39 0.0004
828 PREMATURE BABY 11 0.0004
829 WEIGHT DECREASED 102 0.0004
830 MULTIPLE FRACTURES 6 0.0004
831 OSTEONECROSIS OF JAW 9 0.0004
832 MOBILITY DECREASED 26 0.0004
833 STEVENS-JOHNSON SYNDROME 8 0.0004
834 INFECTION 52 0.0004
835 RASH PAPULAR 8 0.0004
836 EXPOSURE DURING PREGNANCY 22 0.0004
837 URINARY TRACT INFECTION 60 0.0004
838 DRUG DEPENDENCE 56 0.0003
839 PRODUCT ADMINISTRATION ERROR 7 0.0003
840 DECREASED APPETITE 80 0.0003
841 JOINT STIFFNESS 9 0.0003
842 FATIGUE 266 0.0003
843 METASTASES TO LIVER 6 0.0003
844 DYSPHAGIA 32 0.0003
845 ALOPECIA 66 0.0003
846 GASTROINTESTINAL DISORDER 30 0.0003
847 DYSPNOEA 189 0.0003
848 RENAL IMPAIRMENT 28 0.0003
849 DRY MOUTH 27 0.0003
850 OEDEMA 18 0.0003
851 OSTEOMYELITIS 6 0.0003
852 SKIN LESION 9 0.0003
853 VISION BLURRED 45 0.0003
854 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
855 PROCEDURAL PAIN 9 0.0003
856 DEMENTIA 9 0.0003
857 MUSCULAR WEAKNESS 36 0.0003
858 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
859 PROTEINURIA 6 0.0003
860 HEPATOTOXICITY 7 0.0003
861 FEELING ABNORMAL 75 0.0003
862 RASH GENERALISED 8 0.0003
863 HAEMATOMA 8 0.0003
864 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
865 ASCITES 9 0.0003
866 GASTROINTESTINAL HAEMORRHAGE 25 0.0003
867 ASTHENIA 112 0.0003
868 THROAT TIGHTNESS 8 0.0003
869 EPISTAXIS 22 0.0003
870 RENAL FAILURE 39 0.0003
871 NAUSEA 232 0.0003
872 RIB FRACTURE 6 0.0003
873 INFLUENZA LIKE ILLNESS 24 0.0003
874 CHILLS 34 0.0003
875 GAIT DISTURBANCE 55 0.0003
876 BLOOD GLUCOSE INCREASED 54 0.0003
877 WOUND 8 0.0003
878 MOUTH ULCERATION 6 0.0003
879 FLATULENCE 16 0.0003
880 IMPAIRED WORK ABILITY 6 0.0003
881 THERAPY INTERRUPTED 20 0.0003
882 NIGHT SWEATS 9 0.0003
883 DRUG EFFECT DECREASED 15 0.0003
884 ABDOMINAL PAIN LOWER 7 0.0003
885 MELAENA 6 0.0003
886 BACK PAIN 63 0.0003
887 LIP SWELLING 9 0.0003
888 DYSPNOEA EXERTIONAL 10 0.0003
889 LUNG DISORDER 13 0.0003
890 EAR INFECTION 7 0.0003
891 TINNITUS 12 0.0003
892 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
893 EYE IRRITATION 15 0.0003
894 CELLULITIS 13 0.0003
895 CEREBRAL HAEMORRHAGE 9 0.0003
896 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
897 MUSCULOSKELETAL PAIN 13 0.0002
898 INTERSTITIAL LUNG DISEASE 12 0.0002
899 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
900 NEURALGIA 6 0.0002
901 SWELLING FACE 16 0.0002
902 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
903 CHEST DISCOMFORT 25 0.0002
904 CEREBROVASCULAR ACCIDENT 41 0.0002
905 INJURY 17 0.0002
906 RASH PRURITIC 13 0.0002
907 COLITIS 9 0.0002
908 SKIN BURNING SENSATION 17 0.0002
909 DEATH 204 0.0002
910 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
911 RASH 102 0.0002
912 FEBRILE NEUTROPENIA 15 0.0002
913 ANGIOEDEMA 10 0.0002
914 DYSPEPSIA 22 0.0002
915 FREQUENT BOWEL MOVEMENTS 6 0.0002
916 PSORIASIS 29 0.0002
917 NEPHROLITHIASIS 10 0.0002
918 HAEMATOCHEZIA 12 0.0002
919 FEELING COLD 6 0.0002
920 EYE SWELLING 8 0.0002
921 NECK PAIN 12 0.0002
922 PAIN IN JAW 6 0.0002
923 VISUAL ACUITY REDUCED 7 0.0002
924 OCULAR HYPERAEMIA 10 0.0002
925 INTENTIONAL DOSE OMISSION 6 0.0002
926 HEADACHE 128 0.0002
927 MYALGIA 34 0.0002
928 LYMPHADENOPATHY 7 0.0002
929 SKIN DISCOLOURATION 9 0.0002
930 POLLAKIURIA 8 0.0002
931 NERVOUSNESS 10 0.0002
932 ROAD TRAFFIC ACCIDENT 8 0.0002
933 ADVERSE EVENT 17 0.0002
934 CHRONIC KIDNEY DISEASE 14 0.0002
935 STAPHYLOCOCCAL INFECTION 6 0.0002
936 HAEMORRHAGE 19 0.0002
937 DIARRHOEA 117 0.0002
938 URTICARIA 30 0.0002
939 ANGER 6 0.0002
940 PARAESTHESIA 27 0.0002
941 MIGRAINE 16 0.0002
942 PAIN 101 0.0002
943 MUSCLE SPASMS 30 0.0002
944 CARDIAC FAILURE CONGESTIVE 13 0.0002
945 PRODUCT USE ISSUE 30 0.0002
946 ACNE 12 0.0002
947 LIVER DISORDER 7 0.0002
948 HERPES ZOSTER 9 0.0002
949 ABDOMINAL PAIN UPPER 31 0.0002
950 STOMATITIS 9 0.0001
951 BURNING SENSATION 10 0.0001
952 SKIN EXFOLIATION 12 0.0001
953 OSTEOARTHRITIS 6 0.0001
954 RECTAL HAEMORRHAGE 6 0.0001
955 ABDOMINAL DISCOMFORT 23 0.0001
956 SURGERY 8 0.0001
957 COUGH 38 0.0001
958 NEOPLASM MALIGNANT 9 0.0001
959 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
960 ILL-DEFINED DISORDER 8 0.0001
961 RENAL DISORDER 6 0.0001
962 BREAST CANCER 12 0.0001
963 ARTHRITIS 10 0.0001
964 ILLNESS 13 0.0001
965 RASH ERYTHEMATOUS 6 0.0001
966 THROMBOSIS 10 0.0001
967 BRONCHITIS 9 0.0001
968 FLUSHING 12 0.0001
969 CONTUSION 11 0.0001
970 INCORRECT DOSE ADMINISTERED 26 0.0001
971 HYPERSENSITIVITY 21 0.0001
972 PRURITUS 42 0.0001
973 NASOPHARYNGITIS 20 0.0001
974 RHINORRHOEA 7 0.0001
975 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
976 HOT FLUSH 8 0.0001
977 UNEVALUABLE EVENT 8 0.0001
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
979 NEUROPATHY PERIPHERAL 10 0.0001
980 NASAL CONGESTION 6 0.0001
981 DISEASE PROGRESSION 12 0.0001
982 DISCOMFORT 6 0.0001
983 PERIPHERAL SWELLING 15 0.0001
984 ERYTHEMA 20 0.0001
985 DYSGEUSIA 7 0.0001
986 ASTHMA 10 0.0001
987 PAIN IN EXTREMITY 26 0.0001
988 SWELLING 8 0.0001
989 PRODUCT DOSE OMISSION ISSUE 24 0.0001
990 ARTHRALGIA 32 0.0001
991 JOINT SWELLING 9 0.0001
992 DRUG DOSE OMISSION 11 0.0001
993 PRODUCT QUALITY ISSUE 9 0.0001
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
995 NO ADVERSE EVENT 7 0.0000
996 INJECTION SITE PAIN 11 0.0000